by Commetric | Jul 4, 2022 | Blog
The first meeting of the American Society of Clinical Oncology since the start of the pandemic was covered by many pharma publications which followed a wealth of exciting data across the oncology spectrum. Our media analysis found that ASCO gave rise to a new...
by Commetric | May 24, 2022 | Blog
Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople,...
by Commetric | May 13, 2022 | Blog
As pharma experiences continued momentum for immuno-oncology treatments, with the current drug development pipeline consisting of thousands of potential therapies and therapy combinations, the media conversation around immuno-oncology is becoming livelier and...